Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Botulinum toxin A on detrusor contractility in overactive bladder
2007-004650-93Phase 4Active
- Sponsor
- University Medical Center Groningen
- Start
- Aug 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of botulinum toxin type A in overactive bladder (OAB) and neurogenic bladder, sponsored by University Medical Center Groningen. Primary endpoint: Change in detrusor contractility. Started Aug 2007; status: active.
02
Drugs
botulinum toxin type A
03
Conditions
overactive bladder (OAB)neurogenic bladder
Beyond the preview
Go deeper on 2007-004650-93.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004650-93.